Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience gross margin
Gross margin is gross profit as a percentage of revenue.
Zivo Bioscience's gross margin for the twelve months ending Sep 30, 2025 was 31.7%. For fiscal 2024 it was 31.1%, against 42.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 31.1% | −10.9 |
| FY2023 | Dec 31, 2023 | 42.0% | +75.1 |
| FY2011 | Dec 31, 2011 | -33.1% | −70.4 |
| FY2010 | Dec 31, 2010 | 37.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | 32.4% | −2.6 |
| Q2 FY2025 | Jun 30, 2025 | 33.6% | −1.4 |
| Q4 FY2024 | Dec 31, 2024 | 30.0% | −5.0 |
| Q3 FY2024 | Sep 30, 2024 | 30.0% | −52.7 |
| Q1 FY2024 | Mar 31, 2024 | 35.0% | – |
| Q4 FY2023 | Dec 31, 2023 | 35.0% | – |
| Q3 FY2023 | Sep 30, 2023 | 35.0% | – |
| Q2 FY2023 | Jun 30, 2023 | 82.7% | – |
See a number that looks wrong?